Heart Failure: Difference between revisions

Line 1,024: Line 1,024:


===Prognosis===
===Prognosis===
[[Image:Image1.jpg|thumb|right|400px|Figure 9 Two-year mortality in landmark contemporary clinical heart failure trials (from Cleland et al)]]
[[Image:HF_prognosis_trials.svg|thumb|right|400px|Figure 9 Two-year mortality in landmark contemporary clinical heart failure trials (from Cleland et al)]]


The life expectancy of a patient with heart failure is determined by age, NYHA class, LVEF, normal level of sodium, systolic blood pressure, use of medication and use of ICD or CRT-D (Seattle Heart failure score). The mean yearly annual mortality is about 10%, varying from <6% per year when a normal LVEF is found, to > 14% per year with an EF of < 15%.  
The life expectancy of a patient with heart failure is determined by age, NYHA class, LVEF, normal level of sodium, systolic blood pressure, use of medication and use of ICD or CRT-D (Seattle Heart failure score). The mean yearly annual mortality is about 10%, varying from <6% per year when a normal LVEF is found, to > 14% per year with an EF of < 15%.  
Trials with medication illustrate that the (short term) benefit of medication is highest when the NYHA class is higher (Figure 9).<cite>11</cite>
Trials with medication illustrate that the (short term) benefit of medication is highest when the NYHA class is higher (Figure 9).<cite>11</cite>


==References==
==References==